Gadeta B.V. , a Clade Therapeutics Inc. company, is a Research & Development company established in 2015 which focusses on the development of innovative immunotherapies for cancer. The work of the company is based on the groundbreaking discoveries regarding the role of γδ T cell receptors (TCRs) in the broad recognition of both hematological and solid tumor cells and their potential use for the treatment of advanced malignancies as discovered by Prof. Dr. Jürgen Kuball, at the University Medical Centre Utrecht (UMCU), The Netherlands. The Gadeta office and laboratory is located in the Bio Incubator next to the UMCU and collaborates with top-tier international scientists to achieve its goals.
View Top Employees from GadetaWebsite | https://www.gadeta.nl/ |
Revenue | $7 million |
Funding | $7.8 million |
Employees | 35 (35 on RocketReach) |
Founded | 2015 |
Address | Yalelaan 62, Utrecht, Utrecht 3584CM, NL |
Phone | +31 85 016 4466 |
Technologies |
HTML,
Twitter,
Microsoft Outlook
+3 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Immunotherapies, Pharmaceuticals, Science and Engineering, Oncology, Healthcare, Medical, Cellular Therapies, Health Care, Immunology, Therapeutics |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies |
Looking for a particular Gadeta employee's phone or email?
The Gadeta annual revenue was $7 million in 2024.
35 people are employed at Gadeta.
Gadeta is based in Utrecht, Utrecht.
The NAICS codes for Gadeta are [541, 541714, 5417, 54, 54171].
The SIC codes for Gadeta are [873, 87].